Devin Whittemore Smith is General Counsel of IO Biotech, Inc.. Currently has a direct ownership of 16,938 shares of IOBT, which is worth approximately $15,413. The most recent transaction as insider was on Dec 23, 2024, when has been sold 12,000 shares (Common Stock) at a price of $0.81 per share, resulting in proceeds of $9,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.9K
243.01% 3M change
243.01% 12M change
Total Value Held $15,413

Devin Whittemore Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Open market or private purchase
$9,720 $0.81 p/Share
12,000 Added 41.47%
16,938 Common Stock
Aug 09 2023
BUY
Grant, award, or other acquisition
$9,382 $1.9 p/Share
4,938 Added 50.0%
4,938 Common Stock

Also insider at

NERV
Minerva Neurosciences, Inc. Healthcare
YMTX
YUMANITY THERAPEUTICS, INC. Healthcare
DWS

Devin Whittemore Smith

General Counsel
Waltham, MA

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Track Activities on IOBT